Pulmonaryhypertensionnews.com1h
TX45 improves heart function, blood flow in PH-HFpEF
Tectonic Therapeutic said the findings support the design and population for Phase 2 APEX trial, which will test TX45 in ...
Pulmonaryhypertensionnews.com3d
Early Winrevair trial end to allow all patients to start active treatment
Merck is ending a Phase 3 trial of Winrevair early so all PAH patients in HYPERION can start active treatment with the drug ...
Pulmonaryhypertensionnews.com5d
Right heart size differs between men and women with PAH: Study
Men with PAH had a larger right heart size and worse survival than women, independent of body size and functional status, a ...
Pulmonaryhypertensionnews.com7d
LungFit PH NO therapy device wins marketing approval in Australia
The LungFit PH device was approved ini 2022 by the U.S. Food and Drug Administration and the European Union to treat PPHN.
Pulmonaryhypertensionnews.com10d
Imaging technique may detect earliest signs of PAH tissue changes
An imaging technique called 18F-FAPI PET may be able to detect early signs of changes in blood vessel tissues in PAH, a new ...
Pulmonaryhypertensionnews.com4d
How my grandparents supported my family through the years
Columnist Anna Jeter appreciates how much her maternal grandparents meant to her family as she dealt with pulmonary hypertension.
Pulmonaryhypertensionnews.com12d
Adempas helps lower risk in PAH patients, newer risk model confirms
A possibly more precise risk model showed Adempas helped PAH patients at intermediate risk of death arrive at more favorable prognosis.